| scholarly article | Q13442814 |
| P2093 | author name string | Leppert M | |
| Slattery ML | |||
| Curtin K | |||
| Ma KN | |||
| Samowitz WS | |||
| Schaffer D | |||
| Coleman LW | |||
| P433 | issue | 9 | |
| P921 | main subject | colon cancer | Q18555025 |
| microsatellite | Q265193 | ||
| P304 | page(s) | 917-923 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| P1476 | title | Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level | |
| P478 | volume | 10 |
| Q39207356 | A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803. |
| Q37283757 | A comparison of colon and rectal somatic DNA alterations |
| Q47121404 | A complex microsatellite at chromosome 7q33 as a new prognostic marker of colorectal cancer |
| Q36775381 | A retrospective observational study of the relationship between family history and survival from colorectal cancer |
| Q30780611 | Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data |
| Q35596248 | Aetiology of colorectal cancer and relevance of monogenic inheritance |
| Q37448192 | An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression |
| Q83254020 | Analysis of colorectal cancer morphology in relation to sex, age, location, and family history |
| Q34017781 | Analysis of microsatellite instability in stool DNA of patients with colorectal cancer using denaturing high performance liquid chromatography |
| Q55263315 | Appendiceal carcinoma associated with microsatellite instability. |
| Q89843964 | Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies |
| Q35896499 | Association of Dietary Quercetin With Reduced Risk of Proximal Colon Cancer |
| Q37271129 | Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer |
| Q36739632 | Association of family history with cancer recurrence and survival among patients with stage III colon cancer. |
| Q35721124 | Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials |
| Q37382206 | Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status |
| Q36689001 | Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer |
| Q33906044 | BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome |
| Q36968539 | Biomarker use in colorectal cancer therapy |
| Q35583180 | Cancer immunology--analysis of host and tumor factors for personalized medicine |
| Q35622839 | Challenges in the Management of Stage II Colon Cancer |
| Q36693771 | Chemotherapeutic implications in microsatellite unstable colorectal cancer |
| Q38094098 | Chemotherapy of MMR-deficient colorectal cancer |
| Q40505485 | Classification and characterization of microsatellite instability across 18 cancer types |
| Q37144362 | Clinical implications of microsatellite instability in sporadic colon cancers |
| Q38480575 | Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine |
| Q51390015 | Clinicopathologic features and prognostic analysis of MSI-high colon cancer |
| Q27003134 | Colorectal Cancer Biomarkers: Where Are We Now? |
| Q37578721 | Colorectal cancer disparities: issues, controversies and solutions |
| Q26768427 | Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances |
| Q37139194 | Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis |
| Q52658497 | Comparison of survival between right-sided and left-sided colon cancer in different situations. |
| Q62937164 | Comparison of three commonly used PCR-based techniques to analyze MSI status in sporadic colorectal cancer |
| Q47151468 | Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer |
| Q64083490 | Cross-platform Data Analysis Reveals a Generic Gene Expression Signature for Microsatellite Instability in Colorectal Cancer |
| Q37158248 | DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer |
| Q35031411 | DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. |
| Q37081098 | Deficient mismatch repair system in patients with sporadic advanced colorectal cancer |
| Q61865602 | Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status |
| Q34391153 | Differential colorectal carcinogenesis: Molecular basis and clinical relevance |
| Q55430065 | Disparities in survival for right-sided vs. left-sided colon cancers in young patients: a study based on the Surveillance, Epidemiology, and End Results database (1990–2014). |
| Q95361082 | Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancer |
| Q37426594 | Efficient and reproducible identification of mismatch repair deficient colon cancer: validation of the MMR index and comparison with other predictive models |
| Q89849938 | Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions |
| Q38683093 | Expending Role of Microsatellite Instability in Diagnosis and Treatment of Colorectal Cancers. |
| Q38994686 | Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer |
| Q33918795 | Four Molecular Subtypes of Colorectal Cancer and Their Precursor Lesions |
| Q91938581 | GLTSCR1 Negatively Regulates BRD4-Dependent Transcription Elongation and Inhibits CRC Metastasis |
| Q50151129 | Gallstones Are Associated with Colonic Adenoma: A Meta‐analysis |
| Q55058836 | Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer. |
| Q34638183 | Genetic alterations in colorectal cancer |
| Q34008801 | Genetic predisposition to colorectal cancer: where we stand and future perspectives |
| Q37343499 | Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis |
| Q34277961 | Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer |
| Q36334742 | Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer |
| Q33596492 | Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability |
| Q37155318 | High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas |
| Q42003363 | Histopathological growth pattern, proteolysis and angiogenesis in chemonaive patients resected for multiple colorectal liver metastases |
| Q92146631 | IS THERE A DIFFERENCE BETWEEN RIGHT- VERSUS LEFT-SIDED COLON CANCERS? DOES SIDE MAKE ANY DIFFERENCE IN LONG-TERM FOLLOW-UP? |
| Q39387816 | Immune Checkpoints as a Target for Colorectal Cancer Treatment. |
| Q26772272 | Implications of mismatch repair-deficient status on management of early stage colorectal cancer |
| Q35321686 | Improved survival among colon cancer patients with increased differentially expressed pathways |
| Q59125939 | Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients |
| Q38761790 | Infrequently expressed miRNAs in colorectal cancer tissue and tumor molecular phenotype |
| Q74598667 | Investigation of microsatellite instability in Turkish breast cancer patients |
| Q35233954 | KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer |
| Q39642103 | KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis |
| Q36414307 | LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer. |
| Q30395541 | Leptomeningeal metastasis as initial manifestation of signet ring colorectal adenocarcinoma: a case report with review of literature |
| Q35597157 | Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma |
| Q38423068 | Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer |
| Q36259687 | Lynch syndrome (hereditary non-polyposis colorectal cancer): current concepts and approaches to management |
| Q36413436 | MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients. |
| Q34238514 | Microsatellite instability among individuals of Hispanic origin with colorectal cancer |
| Q37471795 | Microsatellite instability and B-type Raf proto-oncogene mutation in colorectal cancer: Clinicopathological characteristics and effects on survival |
| Q35170271 | Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803. |
| Q33954707 | Microsatellite instability and survival in rectal cancer |
| Q36776983 | Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series |
| Q90609132 | Microsatellite instability in colorectal cancer |
| Q28247135 | Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases |
| Q83835402 | Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications |
| Q36338134 | Microsatellite instability in gastrointestinal tract cancers: a brief update |
| Q36124008 | Microsatellite instability testing and its role in the management of colorectal cancer. |
| Q44003216 | Microsatellite instability testing in Korean patients with colorectal cancer |
| Q36685431 | Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance |
| Q33862772 | Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico |
| Q35760529 | Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer |
| Q33792250 | Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients |
| Q33884012 | Molecular Diagnostics of Colorectal Cancer |
| Q37680161 | Molecular genetics of microsatellite-unstable colorectal cancer for pathologists |
| Q24617331 | Molecular origins of cancer: Molecular basis of colorectal cancer |
| Q35836592 | Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications |
| Q34039306 | Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results–Medicare Data |
| Q52633432 | Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers |
| Q37672216 | Octogenarian patients with colorectal cancer: Characterizing an emerging clinical entity |
| Q28066110 | Opportunities for immunotherapy in microsatellite instable colorectal cancer |
| Q36404900 | Pathologic predictors of microsatellite instability in colorectal cancer |
| Q33848817 | Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses |
| Q35891841 | Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC in the English National Health Service |
| Q37165280 | Prognostic and Predictive Impact of DNA Mismatch Repair in the Management of Colorectal Cancer |
| Q33735239 | Prognostic and predictive significance of MSI in stages II/III colon cancer |
| Q34982575 | Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy |
| Q64997225 | Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer. |
| Q53639179 | Prognostic significance of microsatellite instability in sporadic colorectal cancer |
| Q43214606 | Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer |
| Q34801092 | Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry |
| Q35605611 | Reg gene family and human diseases |
| Q33213711 | Relationships of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancers |
| Q53650635 | Robust microsatellite instability (MSI) analysis by denaturing high-performance liquid chromatography (DHPLC). |
| Q24643420 | SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology |
| Q42769381 | Serrated pathway: Alternative route to colorectal cancer |
| Q37645004 | Site-specific associations between miRNA expression and survival in colorectal cancer cases |
| Q33232550 | Smad4-expression is decreased in breast cancer tissues: a retrospective study |
| Q33857897 | Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer |
| Q34961305 | Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry. |
| Q54337693 | T([20]) repeat in the 3'-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer. |
| Q36947020 | The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer |
| Q38634905 | The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis |
| Q34777098 | The influence of the CHIEF pathway on colorectal cancer-specific mortality |
| Q37142001 | The role of molecular markers in predicting response to therapy in patients with colorectal cancer |
| Q53372663 | Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior |
| Q40757402 | Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer |
| Q38356774 | Understanding the colon cancer stem cells and perspectives on treatment. |
| Q38324281 | Using tumour phylogenetics to identify the roots of metastasis in humans. |
| Q38327592 | Villin expression is frequently lost in poorly differentiated colon cancer. |
Search more.